Goldman Sachs Group »

Karyopharm Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 1.3M 0.87
2023-09-30 $2.6M 1.9M 1.34
2023-06-30 $2.9M 1.6M 1.79
2023-03-31 $5.7M 1.5M 3.89
2022-12-31 $3.6M 1.1M 3.40
2022-06-30 $6.5M 1.4M 4.51
2022-03-31 $6.6M 899k 7.37
2021-12-31 $6.6M 1.0M 6.43
2021-09-30 $5.7M 985k 5.82
2021-03-31 $13M 1.2M 10.52
2020-12-31 $16M 1.1M 15.48
2020-09-30 $13M 865k 14.60
2020-06-30 $38M 2.0M 18.94
2019-12-31 $11M 556k 19.17
2019-09-30 $5.5M 576k 9.62
2019-06-30 $993k 166k 5.99
2019-03-31 $955k 164k 5.84
2018-12-31 $1.5M 161k 9.37
2018-09-30 $4.7M 279k 17.03
2018-06-30 $8.6M 508k 16.99
2018-03-31 $1.5M 112k 13.42
2017-12-31 $750k 78k 9.60
2017-09-30 $887k 81k 10.98
2017-06-30 $426k 47k 9.06
2017-03-31 $1.0M 80k 12.84
2016-12-31 $956k 102k 9.40
2016-09-30 $472k 49k 9.73
2016-06-30 $277k 41k 6.71
2016-03-31 $96k 11k 8.93
2015-09-30 $4.6M 441k 10.43
2015-06-30 $5.1M 186k 27.22
2015-03-31 $4.7M 153k 30.60
2014-12-31 $1.6M 44k 37.43
2014-03-31 $663k 22k 30.90